SLAS Technology Idea Exchange: NexusXp People's Choice Award Winner -A Future for Drug Discovery

This SLAS Technology Idea Exchange features three companies from the inaugural SLAS NexusXp People's Choice Award-winning collaboration: "TEST," - The Future of Drug Discovery: DeepCure's AI and Robotics Driven Pipeline.

DeepCure is accelerating drug discovery through AI, robotics and advanced informatics. A fully integrated hardware and software solution was deployed to synthesize, purify and advance 5,000 to 10,000 new compounds every month through the development pipeline. Design-Make-Test-Analyze (DMTA) was fully automated and increased laboratory efficiency by orders of magnitude. This was accomplished through deep collaboration between DeepCure, Waters and Biosero.

Representing TEST for this T.I.E. will be Thrasyvoulos Karydis (DeepCure), Dustin Whitson (Biosero), and Andrew Leightner (Waters), with Hayley Dyer (Biosero) and SLAS Scientific Manager Emily Yamasaki, Ph.D., serving as moderators.

Key:

Complete
Failed
Available
Locked
SLAS Technology Idea Exchange - NexusXp People's Choice Award Winners: A Future for Drug Discovery
Select the "View On-Demand Recording" button to begin.  |  60 minutes
Select the "View On-Demand Recording" button to begin.  |  60 minutes This SLAS Technology Idea Exchange features three companies from the inaugural SLAS NexusXp People's Choice Award-winning collaboration: "TEST," as the collaborators present The Future of Drug Discovery: DeepCure's AI and Robotics Driven Pipeline. DeepCure is accelerating drug discovery through AI, robotics and advanced informatics. A fully integrated hardware and software solution was deployed to synthesize, purify and advance 5,000 to 10,000 new compounds every month through the development pipeline. Design-Make-Test-Analyze (DMTA) was fully automated and increased laboratory efficiency by orders of magnitude. This was accomplished through deep collaboration between DeepCure, Waters and Biosero. Representing TEST for this T.I.E. are Thrasyvoulos Karydis (DeepCure), Dustin Whitson (Biosero), and Andrew Leightner (Waters), with Hayley Dyer (Biosero) and SLAS Scientific Manager Emily Yamasaki, Ph.D., serving as moderators.
You must register to access.